Photo: Pixabay
Healthcare-focused private equity firm InvAscent has secured $115.6 million so far for its latest life sciences fund from US-based investors, according to a filing with the Securities and Exchange Commission (SEC).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Printed by Unregistered user on Fri, 28 Jun 2024 00:44:18 GMT